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In the context of comparative research, the World Health Organisation (WHO)
proposed to categorise the risk for alcohol-related acute and chronic harm accord-
ing to patients’ average daily alcohol consumption. OBJECTIVES: To estimate util-
ity scores associated with each category of the WHO drinking risk-level classifica-
tion in patients with alcohol dependence (AD). METHODS: We used data from
CONTROL, an observational cohort study including 143 AD patients from the Alco-
hol Treatment Center at Lausanne University Hospital, followed for 12 months.
Average daily alcohol consumption was assessed monthly using the Timeline Fol-
low-back method and patients were categorised according to the WHO drinking
risk-level classification: abstinent, low, medium, high and very high. Other mea-
sures as sociodemographic characteristics and utility scores derived from the Eu-
roQoL 5-Dimensions questionnaire (EQ-5D) were collected every three months.
Mixed models for repeated measures were used to estimate mean utility scores
associated with WHO drinking risk-level categories. RESULTS: A total of 143 pa-
tients were included and the 12-month follow-up permitting the assessment of
1318 person-months. At baseline the mean age of the patients was 44.6 (SD 11.8)
and the majority of patients was male (63.6%). Using repeated measures analysis,
utility scores decreased with increasing drinking levels, ranging from 0.80 in absti-
nent patients to 0.62 in patients with very high risk drinking level (p0.0001).
CONCLUSIONS: In this sample of patients with alcohol dependence undergoing
specialized care, utility scores estimated from the EQ-5D appeared to substantially
and consistently vary according to patients’ WHO drinking level.
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OBJECTIVES:Major Depressive Disorder (MDD) has a profound negative impact on
sufferers’ lives. This analysis sought to identify differences in patient characteris-
tics and outcomes associatedwith self-report of depression and use of prescription
treatment within a positively-screened MDD population. METHODS: Data were
taken from the US 2011 National Health and Wellness Survey (n75,000), a cross-
sectional Internet-based survey representative of US adults. Patients with MDD
were identified using the Patient Health Questionnaire (PHQ-9). Health-related
quality of life (HRQoL) was assessed with the SF-12 Health Survey (SF-12v2), and
activity impairment was measured with the Work Productivity and Activity Im-
pairment questionnaire (WPAI). Comparisons between patient groups were made
with chi-square tests for categorical variables and ANOVA for continuous
variables. RESULTS: PHQ-9 scores identifiedMDD in 6.3% of respondents (n4,720);
33.5% (n1,583) reported depression and prescription treatment, 30.0% (n1418)
reported depression without prescription treatment, and 36.4% (n1719) did not
self-report depression. Compared to those who did not self-report depression,
treated patients were more likely to have severe depression according to PHQ-9
scores (32.5% vs. 22.2%), had lower mental HRQoL (28.5 vs. 37.3), and more activity
impairment (60.5% vs. 47.4%) (ps0.001); however, fewer treated patients visited
the emergency room in the past 6 months (25.0% vs. 21.3%, p0.001). Patients who
did not report depression were more likely to have completed college (34.6% vs.
30.6%) and had higher incomes (37.6% with incomes over $50,000 vs. 32.4%), but
were less likely to have insurance (70.5% vs. 80.6%), and those with insurance were
less likely to have prescription drug coverage (60.2% vs. 74.4%) (ps0.001).
CONCLUSIONS: Patients who had MDD according to PHQ-9 but did not report de-
pression had less severe depression and a highermental QoL than treated patients,
but still had poor health outcomes. Less comprehensive insurance coverage may
be a barrier in seeking treatment.
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OBJECTIVES: The purpose of this study is to identify factors that predict whether
clientswill respond that theywere “generally satisfied”with services received from
Kentucky Community Mental Health Centers (CMHCs) in 2010. METHODS: Ken-
tucky Cabinet for Health and Family Services, Department for Behavioral Health
Developmental and Intellectual Disabilities (BHDID) conducted a survey to evalu-
ate consumers’ satisfaction with services delivered at the CMHCs in Kentucky. The
surveywas administered at outpatient clinics operated by CMHCs. The validity and
reliability of the survey were reviewed and a logistic regression model was devel-
oped using respondents’ characteristics and their responses about several aspects
of services. RESULTS: During the fiscal year 2010 (7/1/2009  6/30/2010), 117,526
adult patients visited Kentucky CMHCs and 7,029 of them participated in the sur-
vey, resulting in a 5.98% penetration rate. Logistic regression analyses show that
positive perceptions of access, quality and participation in treatment planning
significantly increase positive responses for general satisfaction by 21%, 27% and
5%, respectively. (dy/dx 0.21, 0.27 and 0.05, p0.05) Females are shown to bemore
likely to respond positively on general satisfaction (dy/dx 0.01, p0.05). Age, race
and regional characteristics (rural/urban) were not significantly related to re-
sponses to general satisfaction at the 95% confidence level. CONCLUSIONS: Re-
sponses to general satisfaction are more associated with responses to other do-
mains than respondents’ demographic characteristics. More specifically, the
domains of access, quality, and participation in treatment planning are stronger
predictors of a positive response on the “general satisfaction” question, suggesting
that more attention to those domains of service could positively influence mental
health care recipients’ responses regarding general satisfaction.
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OBJECTIVES: To assess psychometric properties of the Patient Satisfaction with
Pharmacist Services Questionnaire (PSPSQ) in a pharmacist-managed outpatient
psychiatric care clinic.METHODS: This descriptive, cross-sectional study was con-
ducted at a pharmacist-managed psychiatric care clinic in a behavioral healthcare
facility in Southern California between Nov. 2011 and Jan. 2012. Patients were
included if theywere18 years of age and able to read English. PSPSQ consists of 22
items assessed on a four point Likert scale, and hypothesized to have three do-
mains: patient-pharmacist relationship, quality of care and overall satisfaction.
This study was approved by the Institutional Review Board for exempt status.
PSPSQ has been previously tested for face and content validity and is being vali-
dated in other pharmacist managed Disease State Management clinics. Data col-
lected following patients’ visit were analyzed descriptively. Correlations were ex-
amined between age, gender, education, insurance status and patient satisfaction.
Scale reliability was assessed using Cronbach’s alpha and construct validity using
factor analysis. RESULTS: Thirty-five participants completed the survey. Mean age
of participants was 41 years, 54% were male, 37.9% were Caucasian and Hispanic
each, 81% had some college education, and 80% were covered by private health
insurance. Cronbach’s alpha of the tool was 0.971 indicating very high reliability.
After excluding two items, factor analysis yielded 19 items loading on three factors
accounting for 79.6% of the variance. Only one item loaded on a factor different
than hypothesized. The overall mean score of 3.5/4 indicated patient satisfaction
with the pharmacist services they received. Patients with private insurance
showed greater satisfaction compared to others (p0.05). CONCLUSIONS: Our re-
sults suggest that the PSPSQ can serve as a reliable and valid tool for measuring
patient satisfaction with pharmacist clinical services in a community/ambulatory
care setting. Further research is needed to confirm its utility in other pharmacy
practice settings.
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OBJECTIVES: To assess the impact of severity of autism spectrum disorders (ASD)
on caregiver burden and satisfaction with school district services.METHODS: Sur-
vey datawas collected from 301 primary caregivers of childrenwith ASD. Caregiver
burden was measured using the Caregiver Strain Questionnaire (CGSQ) and ASD
severity in childrenwasmeasured using the ChildhoodAutismRating Scale-Parent
version (CARS-P) for functional impairments and Developmental Behavior Check-
list- Parent version (DBC-P24) for behavior problems. Children with ASD were clas-
sified into high and low severity subgroups based on the scores received on CARS-P
and DBC-P24, respectively. One-way analysis of variance (ANOVA) was performed
to assess differences in caregiver burden scores and satisfaction with seven types
of school district services between high and low severity subgroups. One-way AN-
COVA was performed to determine the mediating effect of caregiver burden be-
tween ASD severity and satisfaction with school district services. RESULTS: An
overall significant effect on caregiver burden scoreswas observed for both behavior
problems (F (1,299) 55.4, p0.001) and functional impairments (F (1,299)  42.5,
p0.001) sub-groups. Higher scores were reported for the high behavior problems
(Mean8.3, S.E0.13) and the high functional impairments groups (Mean 8.4,
S.E0.15). Satisfactionwith all school district services except for occupational ther-
apy differed significantly between the severity sub-groups. Caregivers of children
with ASD in high behavior problems and high functional impairments groups re-
ported lower satisfaction with services. The ANCOVA, however, showed no signif-
icant differences in service satisfaction between the severity sub-groups suggest-
ing a mediating role of caregiver burden. CONCLUSIONS: Severity of a child’s ASD
as defined by a combination of the extent of functional impairments and behavior
problems was found to be associated with higher caregiver burden and greater
dissatisfaction with services. Clinical diagnosis of ASD severity alone may not
predict the extent of unmet school service needs.
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OBJECTIVES: To examine psychiatrists’ preferences for specific attributes of anti-
psychotics in the treatment of schizophrenia.METHODS: A discrete choice exper-
iment (DCE) was administered to psychiatrists to examine 7 attributes of antipsy-
chotics (efficacy, mode of administration, formulary access, onset of action, dosing
frequency, safety, and side effects). Psychiatrists were presented with 18 total
choices and asked to indicate which of 2 hypothetical medications they preferred.
Choices were divided among 3 profiles of patients with schizophrenia (average
patient, symptomatic nonadherent patient, and chronic nonadherent patient). De-
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